2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

SESSION

101. Red Cells and Erythropoiesis, Excluding Iron: Poster III

Program: Poster Abstract Session
Monday, December 14, 2026
06:00 p.m. - 08:00 p.m.
MCCNO - Hall F
Technology and Procedures, Assays, Molecular Testing, Profiling, Treatment Considerations, Combination Therapy, Therapy Sequence, Biological Therapies, Antibody Therapy, Non-Biological Therapies, Artificial Intelligence (AI), Machine Learning, Biological Processes, Apoptosis, Pathogenesis, CHIP, Genomics, Hematopoiesis, Immune Mechanism, Metabolism, Molecular Biology, Clinical Practice (Health Services and Quality), Clinical Guidelines, Quality of Care, Diseases, Bone Marrow Failure Syndromes, Genetic Disorders, Hemoglobinopathies, Immunology, Autoimmune Disorders, Autoimmune Hemolytic Anemia, Infectious Diseases, Other Pathogens, Metabolic Disorders, Research, Fundamental Science, Translational Research, Clinical Research, Clinical Trials, Real-World Evidence, Registries, Study Population, Human, Adult, Elderly, Young Adult, Animal Model
PAPER

4640 Identification of novel variants and genotype-phenotype correlations in hereditary spherocytosis using targeted next-generation sequencing

Jinya Gao, ?, Long Chen2, Jianing Tang3, Hong Zhang4, Yani Lin, PhD5, Kun Ru6
1 Sino-US Diagnostics Lab, Tianjin, China
2 Sino-US Diagnostics Lab, Tianjin, China
3 Sino-US Diagnostics Lab, Tianjin, China
4 Sino-US Diagnostics Lab, Tianjin, China
5 Sino-US Diagnostics Lab, Tianjin, China
6 Shandong Cancer Hospital and Institute, Shandong, China

Abstract

Background: Hereditary spherocytosis (HS) is the most common inherited disorder of the erythrocyte membrane, with marked clinical and genetic heterogeneity. Genotype–phenotype correlations in HS remain incompletely characterized. In this study, we used targeted next-generation sequencing (NGS) to delineate the mutational spectrum and explore genotype–phenotype associations in a cohort of Chinese patients with suspected HS.

 

Methods: Targeted NGS of five HS-associated genes (ANK1, SPTB, SLC4A1, SPTA1, and EPB42) was performed. Identified variants were interpreted according to ACMG (American College of Medical Genetics and Genomics) guidelines. Laboratory data, including complete blood counts, bilirubin fractions, and eosin-5-maleimide (EMA) binding test results, were collected for correlation analysis.

 

Results: The cohort comprised 77 patients (43 males, 34 females; median age 11.5 years, range 2 months–80 years). A total of 80 variants (77 distinct mutations) were identified. Gene distribution: SPTB 29 (37.7%), ANK1 21 (27.3%), SLC4A1 15 (19.5%), SPTA1 10 (12.9%), and EPB42 2 (2.6%). Truncating mutations predominated: nonsense 25 (32.5%), frameshift 17 (22.1%), canonical splice-site 14 (18.2%), and non-canonical splice-site 6 (7.8%); missense variants accounted for 8 (10.4%). No recurrent hotspot mutations were found. Twenty-six variants (33.8%) were novel, of which 24 were classified as pathogenic or likely pathogenic and 2 as variants of uncertain significance. Novel variants included 10 SPTB, 9 ANK1, 3 SLC4A1, and 4 SPTA1 mutations; types: 2 nonsense, 13 frameshift, 8 canonical splice-site, 2 non-canonical splice-site, and 1 deletion-insertion. Genotype–phenotype analysis showed that SLC4A1 mutations were associated with older age at diagnosis (P=0.0263). Splice-site variants correlated with younger diagnostic age (P=0.0266), while missense variants correlated with older diagnostic age (P=0.0266). Patients with ANK1 or SPTA1 mutations (combined group) had significantly lower EMA binding values (P=0.0357) and a higher proportion of females (P=0.0185). Conversely, the combined SPTB and SLC4A1 group had a higher proportion of males (P=0.0185). SLC4A1 mutations tended toward higher mean corpuscular hemoglobin levels, though not statistically significant (P=0.1277). No other significant associations were found between genotypes or variant types and hemoglobin, mean corpuscular volume, mean corpuscular hemoglobin concentration, red blood cell count, total bilirubin, direct bilirubin, indirect bilirubin, or EMA values.

 

Conclusion: This study describes the genetic landscape of HS in a Chinese cohort, with SPTB and ANK1 as the most frequently mutated genes. We identified 26 novel variants, broadening the known mutational spectrum. Several genotype–phenotype correlations were observed: SLC4A1 mutations and missense variants were associated with older age at diagnosis, splice-site variants with younger age, and ANK1/SPTA1 mutations with reduced EMA binding and a female predominance. These findings support targeted NGS as a valuable tool for molecular diagnosis, clinical management, and genetic counseling in HS.

Jinya Gao, ?: No relevant conflicts of interest to declare.